Talk:Sanofi–GSK COVID-19 vaccine: Difference between revisions

Content deleted Content added

Inline

Revision as of 01:09, 12 February 2023

This is the talk page for discussing improvements to the Sanofi–GSK COVID-19 vaccine article.
This is not a forum for general discussion of the article's subject.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

This article has not yet been rated on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

COVID-19 Start‑class Mid‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Medicine Start‑class Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Please add the quality rating to the {{WikiProject banner shell}} template instead of this project banner. See WP:PIQA for details.

Pharmacology Start‑class Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Start	This article has been rated as Start-class on Wikipedia's content assessment scale.
Mid	This article has been rated as Mid-importance on the project's importance scale.

A discussion is taking place to address a potential problem with the redirect VidPrevtyn Beta® and it has been listed for discussion. Readers of this page are welcome to participate at Wikipedia:Redirects for discussion/Log/2023 February 12 § VidPrevtyn Beta® until a consensus is reached. Clovermoss🍀 (talk) 01:09, 12 February 2023 (UTC)[reply]

@@ Line 6: / Line 6: @@
 }}
 {{annual readership}}
+== "[[:VidPrevtyn Beta®]]" listed at [[Wikipedia:Redirects for discussion|Redirects for discussion]] ==
+[[File:Information.svg|30px]]
+A discussion is taking place to address a potential problem with the redirect <span class="plainlinks">[//en.wikipedia.org/enwiki/w/index.php?title=VidPrevtyn_Beta%C2%AE&redirect=no VidPrevtyn Beta®]</span> and it has been listed [[Wikipedia:Redirects for discussion|for discussion]]. Readers of this page are welcome to participate at {{slink|Wikipedia:Redirects for discussion/Log/2023 February 12#VidPrevtyn Beta®}} until a consensus is reached. <!-- from Template:RFDNote --> [[User:Clovermoss|<span style="color:darkorchid">Clovermoss</span><span style="color:green">🍀</span>]] [[User talk:Clovermoss|(talk)]] 01:09, 12 February 2023 (UTC)